Superworth

Pulmonx EPS LUNG

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
−$1.16
Latest quarter, Q2 FY26
−$0.24
Fiscal year 2025
−$1.33

Pulmonx's earnings per share was −$1.16 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.24.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.33n/a
FY2024−$1.44n/a
FY2023−$1.60n/a
FY2022−$1.59n/a
FY2021−$1.34n/a
FY2020−$11.55n/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.24n/a−$1.16
Q1 FY26−$0.33n/a−$1.30
Q4 FY25−$0.25n/a−$1.33
Q3 FY25−$0.34n/a−$1.41
Q2 FY25−$0.38n/a−$1.43
Q1 FY25−$0.36n/a−$1.44
Q4 FY24−$0.33n/a−$1.44
Q3 FY24−$0.36n/a−$1.47
Q2 FY24−$0.39n/a−$1.50
Q1 FY24−$0.36n/a−$1.54
Q4 FY23−$0.36n/a−$1.60
Q3 FY23−$0.39n/a−$1.62

Against its peers

Companies in Medical - Instruments & Supplies nearest Pulmonx's size, closest first, today.

CompanyEPS, 12 monthsGrowth
LUNGPulmonx−$1.16
KEQUKewaunee Scientific$2.76−33% a year
APTAlpha Pro Tech$0.41+24% a year
NEPHNephros$0.16+33% a year
PDEXPro DEX$4.11+52% a year
UTMDUtah Medical Products$3.28−12% a year
INFUInfuSystem$0.41+78% a year
EMBCEmbecta$1.47+3% a year
TCMDTactile Systems Technology$1.08+74% a year
MDXGMimedx$0.04−81% a year
MOVMovado$1.80+137% a year
Peer median$1.27

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Pulmonx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.